Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating Caplyta for the Prevention of Relapse in Patients With Schizophrenia
Intra-Cellular Therapies宣布,对于评估Caplyta在预防精神分裂症患者复发中的相位3试验的积极头条结果。
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating Caplyta for the Prevention of Relapse in Patients With Schizophrenia
Intra-Cellular Therapies宣布,对于评估Caplyta在预防精神分裂症患者复发中的相位3试验的积极头条结果。
译文内容由第三方软件翻译。
使用浏览器的分享功能,分享给你的好友吧